Dr. Athiya Agarwal has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011.
AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr. Anosh Agarwal (promoter group) transferred 14,41,568 shares (0.455% of the company's diluted share capital) to his mother Dr. Athiya Agarwal as a gift on 19 March 2026. As a result, Dr. Athiya Agarwal's holding rose from 4.00% (1,26,61,975 shares) to 4.45% (1,41,03,543 shares), while Dr. Anosh Agarwal's holding fell from 4.69% to 4.23%. The total promoter and promoter group shareholding in the company remains unchanged, as this is an internal reshuffle between immediate relatives. The transaction was carried out under Regulation 10(1)(a)(i) of SEBI (SAST) Regulations, which exempts inter-se transfers among immediate family members from the open offer requirement. No consideration was involved since the shares were transferred by way of gift.
This is a routine internal family rearrangement within the promoter group and has no material impact on the company's ownership structure or stock price. Shareholders can be reassured that the overall promoter control of Dr. Agarwal's Health Care remains exactly the same.